MCKESSON CORPORATION: Drug Recall
Recall #D-0347-2024 · 02/12/2024
Class II: Risk
Recall Details
- Recall Number
- D-0347-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- MCKESSON CORPORATION
- Status
- Terminated
- Date Initiated
- 02/12/2024
- Location
- IRVING, TX, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42 units
Reason for Recall
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
Product Description
CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic or Intravaginal Use, Rx Only, Net Wt. 50g, Distributed by Bausch Health US, LLC Bridgewater, NJ 08807 USA, Manufactured by: Bausch Health Companies, Inc. Laval Quebec H7L 448, Canada, NDC 0187-0006-25.
Distribution Pattern
Nationwide in the US
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.